Faisal Fakih
Winter Park, FLNPI 1386635480
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Regeneron at 28.4% of the total. Reporting peaked in 2019 at $5,335 and has fallen 61.0% since, to $2,080 in 2024.
Across 34 payments — averaging $221.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$2K
- Astrazeneca UK Limited$2K
- AstraZeneca$1K
- Novartis$1K
- Merck$1K
- Travere Therapeutics, Inc.$42
- plus $14 from 1 others
Across 2,845 payments — averaging $6363.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$10M
- Pfizer$2.6M
- Astrazeneca UK Limited$1.2M
- AstraZeneca$977K
- Alkermes, Inc.$342K
- Takeda Pharmaceuticals U.S.A., Inc.$335K
- plus $2.6M from 21 others
What the payments were for
- Consulting fees$2,08028%
- Travel & lodging$4,15055%
- Food & beverage$1,28717%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 2 | $2,133 |
| Astrazeneca UK Limited | 9 | $1,798 |
| AstraZeneca | 5 | $1,255 |
| Novartis | 10 | $1,139 |
| Merck | 6 | $1,136 |
| Travere Therapeutics, Inc. | 1 | $42 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEVESPI AEROSPHERE$1,226
- MK-7264$1,007
- QBW251$551
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.